Role of Interferon-α and Clonally Expanded T Cells in the Immunotherapy of Chronic Myelogenous Leukemia-Reference-Cited by-同舟云学术

Role of Interferon-α and Clonally Expanded T Cells in the Immunotherapy of Chronic Myelogenous Leukemia

Published:2000-01 Issue:1-2 Volume:38 Page:21-38
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Fujii Shin-Ichiro¹

Affiliation:

1. The Center for Bone Marrow Transplantation and Immunotherapy, Institute for Clinical Research, Kumamoto National Hospital, 1–5 Ninomaru, Kumamoto, 860–0008, Japan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428190009060316

Reference138 articles.

1. A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group

2. The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood

3. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferons: role in cancer therapy;Immunotherapy;2020-08

2. T Cell Responses in Myeloma;Advances in Biology and Therapy of Multiple Myeloma;2012-11-01

3. Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma;BMC Cancer;2012-10-01

4. The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma;Current Medicinal Chemistry;2010-10-01

5. Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenström macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy;Blood;2010-04-29